Overuse of antibiotics is a big problem. New data supports delaying that prescription for kids with respiratory infections.
If it seems to good to be true, it probably is. And ZShield face shields being marketed to the general public certainly fits that description, especially when it comes to their use by children.
The CDC is warning parents and pediatric medical professionals to be on the lookout for a potentially devastating viral disease this fall. It isn't the novel coronavirus, but the impact of the pandemic might make things worse...or better.
Lotus Birth, an "ethically inadmissible" practice where a newborn is left attached to the placenta for several days, is risky, benefit free, and is likely to blame for the death of an Australian infant in 2017.
A mysterious inflammatory condition, likely caused by COVID-19, is affecting a small number of children. We don't know much about it yet, but we are certain to see additional cases and to learn more about why this is happening. Still, it's not time to panic.
Another large data set, this time from the CDC, supports the anecdotal observations that pediatric COVID-19 cases tend to be mild and that a very small percentage of children are requiring intensive care. The absence of obvious symptoms increases the risk of spreading the virus, so social distancing and proper hygiene are key when it comes to kids.
A recent study looked at antibiotic use in thousands of hospitalized children and the results weren't great. Too many kids are receiving suboptimal antibiotic prescriptions. One potential solution is an increased focus on, and improved resources for, antibiotic stewardship programs.
I've gone into the vault in order to save new content until after technical difficulties have been ironed out. Here is one of my earliest and most memorable (to me) posts on the newborn vitamin K shot and risks of refusing it.
A recent study demonstrates an association between reflux medications in infancy and increased risk of fractures in early childhood, yet another reason to be cautious when using pharmaceutical interventions to manage a mostly benign and self-limited condition.